pta20171117030
Release according to article 40 para. 1 WpHG

Medigene AG: Release according to Article 26, Section 1 of the WpHG

Voting Rights Announcement

Planegg (pta030/17.11.2017/20:20 UTC+1) - Release of Voting Rights Announcement

Voting Rights Announcement

1. Details of issuer

Name: Medigene AG
Legal Entity Identifier (LEI): 391200I33JD2DKZGDX06
Street: Lochhamer Straße 11
Postal code: 82152
City: Planegg, Germany

2. Reason for notification
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation
Legal entity: Aviva plc.
City and country of registered office: London, United Kingdom

4. Names of shareholders holding directly 3% or more voting rights, if different from 3.
Aviva Life & Pensions UK Limited

5. Date on which threshold was crossed or reached
13.11.2017

6. Total positions

  % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG
New 4.92 1.64 6.56 22,300,947
Previous notification (if applicable) 0.00 0.00 0.00

7. Details on total positions

a. Voting rights attached to shares (Sec.s 33, 34 WpHG)

ISIN Absolute direct (Sec. 33 WpHG) Absolute indirect (Sec. 34 WpHG) In % direct (Sec. 33 WpHG) In % indirect (Sec. 34 WpHG)
DE000A1X3W00 0 1,097,039 0.00 4.92
Total:    

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

type of instrument Maturity / Expiration Exercise or conversion period Voting Rights Absolute Voting Rights in %
N/A N/A 365,495 1.64
    Total:

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

type of instrument Maturity / Expiration Exercise or conversion period Cash or physical transaction Voting Rights Absolute Voting Rights in %
0 0.00
      Total:

8. Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
Aviva plc
Aviva Group Holdings Limited
Aviva France SA
Aviva plc
Aviva Group Holdings Limited
Aviva Life Holdings UK Limited
Aviva Life & Pensions UK Limited 3.17
Aviva plc
Aviva Group Holdings Limited
Aviva Investors Holdings Limited
Aviva Investors Luxembourg SA
Aviva plc
Aviva Group Holdings Limited
Aviva Investors Holdings Limited
Aviva Investors Global Services Limited 4.92 6.56
Aviva plc
Aviva Group Holdings Limited
Aviva Investors Holdings Limited
Friends Life Funds Limited

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting: N/A

Holding total positions (6.) after general meeting:

Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other useful information

Date
01.01.1970

(end)

Emitter: Medigene AG
Lochhamer Straße 11
82152 Planegg
Germany
Contact Person: Medigene PR/IR
Phone: +49 89 2000 33 3301
E-Mail: investor@medigene.com
Website: www.medigene.de
ISIN(s): DE000A1X3W00 (Share)
Stock Exchange(s): Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate
|